INFORMED.
LIVE

HALEOS LABS LIMITED

BSE: HALEOSLABS540679ISIN INE320X01016
  • Healthcare
  • Pharmaceuticals

Share price

₹1,480.15+6.85 (+0.46%)
as of 18 Sep 2026
HALEOS LABS LIMITED share price, 18 Sep 2025 to 18 Sep 2026: ₹1,223.95 to ₹1,480.15 (+20.9%). Low ₹1,101.60, high ₹1,699.95. Volume shown below the price.
52W high
₹1,778.35
52W low
₹1,100.60
Off 52W high
-16.77%
1M return
+1.30%
3M return
+0.15%
6M return
+15.19%
1Y return
+20.93%
20D avg volume
69
50 DMA
₹1,509.62
200 DMA
₹1,365.92

Key ratios Consolidated

Market cap
₹447.49 Cr
Current price
₹1,480.15
52W high / low
₹1,778.35 / ₹1,100.60
Face value
₹10.00
P/E
29.33
P/B
EPS (TTM)
₹50.47
Book value / share
ROE
ROCE
10.60%
Operating margin
Net margin
Debt / equity
0.47
Net debt
₹107.64 Cr
Interest cover
4.91
Dividend yield
0.10%
Dividend / share (TTM)
₹1.50
Payout
2.97%
Cash conversion cycle
87.2 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
72.9475.1494.7881.3782.5089.11
0.462.010.180.421.002.34
69.9776.2586.1973.3076.4887.52
40.1435.8644.7439.8328.4132.74
-13.680.000.000.000.000.00
17.5516.1716.7016.2316.2916.47
1.901.421.541.621.872.03
4.243.853.913.893.823.80
19.8223.9320.4220.5519.3625.85
3.440.918.788.497.023.93
0.000.000.000.000.000.00
3.440.918.788.497.023.93
1.600.562.132.072.640.45
1.840.346.656.434.383.48
8.751.4421.8920.1913.759.83
Key metrics
9.586.1814.2314.0012.719.76
13.10%8.20%15.00%17.20%15.40%11.00%
2.50%0.50%7.00%7.90%5.30%3.90%
0.80%4.00%2.40%
-11.60%-15.70%
-58.00%-90.20%
MetricTTMFY26FY25FY24
Income statement
324.23333.79344.72
3.072.434.86
305.71311.03323.39
160.57146.69149.91
-13.680.000.00
66.6565.3859.54
6.486.458.71
15.8915.4715.00
84.7285.2386.09
21.6225.2026.19
0.000.000.00
21.6225.2026.19
6.367.407.46
15.2617.8018.73
52.2757.2666.51
Key metrics
43.9947.1249.90
13.57%14.10%14.50%
4.71%5.30%5.40%
10.60%14.10%
-3.20%
-5.00%
-20.6418.70
2.091.82
0.470.40
107.6483.52
87.287.8
Balance sheet
454.41389.99
163.11150.57
1.210.50
61.3468.79
79.8267.40
17.7712.65
266.54230.02
61.4153.27
156.28142.07
108.8584.02
58.8965.75
49.9618.27
229.56212.05
Cash flow
37.2234.05
-57.90-15.00
21.38-19.12
57.8615.35
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
67.8363.3880.7277.8479.0485.43
0.460.970.080.441.012.20
63.0161.1873.3171.2372.5784.29
37.2833.0239.3641.6033.6438.95
-7.830.000.000.000.000.00
13.2512.0612.4612.3812.4912.46
1.811.341.461.511.731.84
3.012.662.692.682.632.62
15.4919.4417.5617.4316.6722.57
5.283.187.497.057.483.33
0.000.000.000.000.000.00
5.283.187.497.057.483.33
2.040.942.082.072.320.66
3.242.235.414.985.162.68
10.717.3917.8816.4617.068.85
Key metrics
10.107.1811.6411.2411.847.79
14.90%11.30%14.40%14.40%15.00%9.10%
4.80%3.50%6.70%6.40%6.50%3.10%
1.70%3.60%2.20%
-14.20%-25.80%
-37.20%-16.80%
MetricTTMFY26FY25FY24
Income statement
289.77300.99333.37
1.951.423.95
268.73277.22307.28
151.26145.57164.43
-7.830.000.00
50.1549.3945.78
6.126.037.88
11.0410.6610.26
69.9272.0674.24
23.0025.1930.04
0.000.000.00
23.0025.1930.04
7.137.418.67
15.8617.7821.37
52.4458.8070.69
Key metrics
40.1641.8848.18
13.86%13.90%14.50%
5.47%5.90%6.40%
11.50%16.20%
-9.70%
-16.80%
-10.8113.94
2.161.31
0.430.40
92.7178.77
85.386.7
Balance sheet
403.34358.31
181.71177.79
0.400.40
54.2664.53
69.8160.58
54.5451.27
188.61148.41
53.7945.98
133.02124.30
93.1179.17
57.9361.86
35.1817.31
214.58197.18
Cash flow
38.4328.03
-49.28-13.77
10.85-14.20
49.2414.09

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Dividend - Rs. - 1.500024 Sep 202524 Sep 2025
Dividend - Rs. - 1.500023 Sep 2024

Board meetings

  • Board Meeting - Financial Results